Exploring genetic factors in gallbladder cancer treatment responses

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the genetic mutations associated with gallbladder cancer and their potential impact on treatment responses. By utilizing next-generation sequencing, the study aims to identify key oncogenes and tumor suppressor genes that may influence patient outcomes. The research focuses on treatment-naïve patients with histologically confirmed gallbladder carcinoma, aiming to bridge the gap between genetic profiling and personalized treatment strategies. The findings could provide insights into the molecular mechanisms driving gallbladder cancer and inform future therapeutic approaches.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Treatment naïve patients with histologically proven carcinoma of the gallbladder.

Exclusion Criteria:

* No histological evidence of malignancy
* Pregnant and lactating women

Where it's running

• Banaras Hindu University
  Varanasi, Uttar Pradesh, India Recruiting

Study contacts

• Principal investigator: Manoj Pandey, Ms, PhD — Banaras Hindu University
• Study coordinator: Manoj Pandey, MS, PhD
• Email: mpandey66@bhu.ac.in
• Phone: 2361014

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CD160-Enhanced Autologous T Cells for Advanced Biliary Tract Cancer

  This trial tests a patient‑made T cell therapy (BTC-Ag-T) to see if it is safe and can help people with advanced biliary tract cancer who have exhausted standard treatments.

  Recruiting Phase 1 Shanghai Zhongshan Hospital · Shanghai · NCT07614061

• Testing MDX2001 for advanced solid tumors

  This study is testing a new drug called MDX2001 to see if it can safely help people with advanced solid tumors like breast or colon cancer.

  Recruiting at 6 sites Phase 1/2 ModeX Therapeutics, An OPKO Health Company · Denver, Colorado and 5 other locations · NCT06239194

• Identifying risk factors for gallbladder cancer and gallstone disease

  This study is trying to find out what causes gallbladder cancer and gallstone disease by looking at different lifestyle and genetic factors to help with early detection and prevention.

  Recruiting at 36 sites Centre Paul Strauss · Salta and 35 other locations · NCT06192719

• Comparing two methods of pain management during laparoscopic gallbladder surgery

  This study is testing whether a new pain management method that combines two techniques can help people feel less pain after gallbladder surgery compared to just one technique.

  Recruiting Helsinki University Central Hospital · Espoo, Uusimaa · NCT06123117

• Combining four drugs for treating unresectable gallbladder cancer

  This study is testing a combination of four drugs to see if it can help people with gallbladder cancer that can't be removed by surgery.

  Recruiting Phase 2 Fudan University · Shanghai · NCT05757336

• Finding new biomarkers for biliary tract cancer and gallbladder cancer

  This study is trying to find new markers in blood and tissue samples from patients with biliary tract and gallbladder cancer to help doctors diagnose the disease earlier and predict how well treatments will work.

  Recruiting Herlev and Gentofte Hospital · Herlev, Copenhagen · NCT05184400

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.